Novartis Institutes for Biomedical Research is a corporate venture arm. Based in Basel, Switzerland. Known portfolio companies include Vor Biopharma, Orna Therapeutics, Pliant Therapeutics, TScan Therapeutics, Surface Oncology and Cadent Therapeutics, 6 companies in all.
Is Novartis Institutes for Biomedical Research a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell TherapyDrug DiscoveryGenomicsPharmaRNA Therapeutics
Novartis Institutes for Biomedical Research portfolio companies (6)
- Vor Biopharma
- Orna Therapeutics
- Pliant Therapeutics
- TScan Therapeutics
- Surface Oncology
- Cadent Therapeutics
Co-investors
Funds that share portfolio companies with Novartis Institutes for Biomedical Research.
Similar funds
Showing 20 of 100
About Novartis Institutes for Biomedical Research
The firm's listing covers sector Healthcare, and focus areas Biotech, Cell Therapy, Drug Discovery and Genomics; known deals cluster at Series A and Series B.
Across the known portfolio, 14 co-investors appear alongside Novartis Institutes for Biomedical Research, including Novartis, Merck and 6 Dimensions Capital.
Frequently asked questions
What is Novartis Institutes for Biomedical Research?
Novartis Institutes for Biomedical Research is a corporate venture arm based in Basel, Switzerland, with a known portfolio of 6 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Novartis Institutes for Biomedical Research invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell Therapy, Drug Discovery and Genomics. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Novartis Institutes for Biomedical Research invest at?
The known deals of Novartis Institutes for Biomedical Research include Series A and Series B rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact Novartis Institutes for Biomedical Research?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal